| __timestamp | Ascendis Pharma A/S | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 90480000 |
| Thursday, January 1, 2015 | 9415000 | 133384000 |
| Friday, January 1, 2016 | 11504000 | 179997000 |
| Sunday, January 1, 2017 | 13482000 | 220119000 |
| Monday, January 1, 2018 | 25057000 | 258528000 |
| Tuesday, January 1, 2019 | 48473000 | 198205000 |
| Wednesday, January 1, 2020 | 76669000 | 181022000 |
| Friday, January 1, 2021 | 160180000 | 198359000 |
| Saturday, January 1, 2022 | 221227000 | 208789000 |
| Sunday, January 1, 2023 | 264410000 | 211124000 |
| Monday, January 1, 2024 | 284545000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Ascendis Pharma A/S and MiMedx Group, Inc. have taken different paths in this regard over the past decade. From 2014 to 2023, Ascendis Pharma A/S saw a staggering increase in SG&A expenses, growing by over 4,100%, from approximately $6.3 million to $264 million. In contrast, MiMedx Group, Inc. experienced a more modest 133% increase, from $90 million to $211 million. This data suggests that while Ascendis Pharma A/S is rapidly expanding its operations, MiMedx Group, Inc. is maintaining a more stable cost structure. Understanding these trends can provide valuable insights into each company's strategic priorities and operational efficiencies.
Selling, General, and Administrative Costs: Novo Nordisk A/S vs MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing Sanofi and MiMedx Group, Inc.
Incyte Corporation and MiMedx Group, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Viatris Inc. and Ascendis Pharma A/S
Cost Management Insights: SG&A Expenses for Intra-Cellular Therapies, Inc. and Ascendis Pharma A/S
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S
Breaking Down SG&A Expenses: Ascendis Pharma A/S vs Blueprint Medicines Corporation
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
Comparing SG&A Expenses: Alkermes plc vs MiMedx Group, Inc. Trends and Insights
Comparing SG&A Expenses: Verona Pharma plc vs MiMedx Group, Inc. Trends and Insights
Perrigo Company plc or MiMedx Group, Inc.: Who Manages SG&A Costs Better?